Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (131-140 of 917) with videos related to

Pageof 92
Sort By:
European Urology|April 23, 2003
Insignificant prostate cancer in radical prostatectomy specimen: time trends and preoperative predictionHerbert Augustin, Peter G Hammerer, Markus Graefen, et al.
Current Opinion in Urology|May 2, 2025
Biochemical recurrence after radical prostatectomy and postoperative radiotherapy: current evidence and controversial issuesMattia Longoni, Fabian Falkenbach, Markus Graefen, et al.
Healthcare (Basel, Switzerland)|May 24, 2024
Value-Based Health Care for Prostate Cancer Centers by Implementing Specific Key Performance Indicators Using a Balanced Score CardJan Philipp Radtke, Peter Albers, Boris A Hadaschik, et al.
The Journal of Urology|June 24, 2018
Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted BiopsiesSami-Ramzi Leyh-Bannurah, Mykyta Kachanov, Dirk Beyersdorff, et al.
European Urology Focus|June 27, 2018
Antimicrobial Lubricant Did Not Reduce Infection Rate in Transrectal Biopsy Patients in a Large Randomized Trial Due to Low Complication RatesGeorg Salomon, Sandra Prues, Judith Saul, et al.
European Urology|December 13, 2025
Re: Rebecca Voelker. What Is Prostate Cancer? JAMA. In press. https://doi.org/10.1001/jama.2025.10177Giorgio Gandaglia, Alberto Briganti, James W Catto, et al.
European Urology|November 26, 2008
Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomyJochen Walz, Felix K H Chun, Eric A Klein, et al.
European Urology|October 17, 2016
High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical ProstatectomyPhilipp Mandel, Felix Preisser, Markus Graefen, et al.
World Journal of Urology|March 20, 2024
PSA-density, DRE, and PI-RADS 5: potential surrogates for omitting biopsy?Fabian Falkenbach, Francesca Ambrosini, Mykyta Kachanov, et al.
European Urology|June 24, 2021
Validation of the STAR-CAP Clinical Prognostic System for Predicting Biochemical Recurrence, Metastasis, and Cancer-specific Mortality After Radical Prostatectomy in a European CohortChristoph Würnschimmel, Randi Marisa Pose, Mike Wenzel, et al.
Pageof 92

Showing results (131-140 of 917) with videos related to

Sort By:
Pageof 92
European Urology|April 23, 2003
Insignificant prostate cancer in radical prostatectomy specimen: time trends and preoperative predictionHerbert Augustin, Peter G Hammerer, Markus Graefen, et al.
Current Opinion in Urology|May 2, 2025
Biochemical recurrence after radical prostatectomy and postoperative radiotherapy: current evidence and controversial issuesMattia Longoni, Fabian Falkenbach, Markus Graefen, et al.
Healthcare (Basel, Switzerland)|May 24, 2024
Value-Based Health Care for Prostate Cancer Centers by Implementing Specific Key Performance Indicators Using a Balanced Score CardJan Philipp Radtke, Peter Albers, Boris A Hadaschik, et al.
The Journal of Urology|June 24, 2018
Anterior Localization of Prostate Cancer Suspicious Lesions in 1,161 Patients Undergoing Magnetic Resonance Imaging/Ultrasound Fusion Guided Targeted BiopsiesSami-Ramzi Leyh-Bannurah, Mykyta Kachanov, Dirk Beyersdorff, et al.
European Urology Focus|June 27, 2018
Antimicrobial Lubricant Did Not Reduce Infection Rate in Transrectal Biopsy Patients in a Large Randomized Trial Due to Low Complication RatesGeorg Salomon, Sandra Prues, Judith Saul, et al.
European Urology|December 13, 2025
Re: Rebecca Voelker. What Is Prostate Cancer? JAMA. In press. https://doi.org/10.1001/jama.2025.10177Giorgio Gandaglia, Alberto Briganti, James W Catto, et al.
European Urology|November 26, 2008
Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomyJochen Walz, Felix K H Chun, Eric A Klein, et al.
European Urology|October 17, 2016
High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical ProstatectomyPhilipp Mandel, Felix Preisser, Markus Graefen, et al.
World Journal of Urology|March 20, 2024
PSA-density, DRE, and PI-RADS 5: potential surrogates for omitting biopsy?Fabian Falkenbach, Francesca Ambrosini, Mykyta Kachanov, et al.
European Urology|June 24, 2021
Validation of the STAR-CAP Clinical Prognostic System for Predicting Biochemical Recurrence, Metastasis, and Cancer-specific Mortality After Radical Prostatectomy in a European CohortChristoph Würnschimmel, Randi Marisa Pose, Mike Wenzel, et al.
Pageof 92